FastUKB: A revolutionary tool for simplifying UK Biobank data analysis

FastUKB is an innovative tool specifically developed to streamline and enhance research workflows utilizing the UK Biobank, effectively addressing key limitations of existing platforms such as the UK Biobank Research Analysis Platform (RAP). One of its most notable features is its breakthrough bulk data extraction functionality, which transforms traditionally complex coding tasks into intuitive click operations. This is made possible through a user-friendly interface equipped with dropdown menus and a hierarchical variable tree structure, allowing researchers to effortlessly navigate and select the data they need. Unlike RAP, which restricts users to selecting only 30 variables at a time—a significant hindrance to analytical efficiency—FastUKB enables the extraction of an unlimited number of variables in a single operation. What’s more, it supports data extraction across multiple entities, including participant data (encompassing basic demographic information and clinical phenotypes), proteomics data from olink_instance, genomics data, neuroimaging and cardiac imaging data, metabolomics data, and physical activity monitoring data from activity_monitor, among others. When compared to existing tools like ukbREST and ukbtools, FastUKB stands out by offering broader batch extraction capabilities, automated field matching, and a much lower technical barrier, making it accessible to a wider range of researchers.​

Beyond data extraction, FastUKB functions as a comprehensive intelligent data processing and analysis hub, providing end-to-end support throughout the research process, from data cleaning to advanced statistical analysis. Its built-in medical-specific quality control module is designed to handle the unique challenges of UK Biobank data, automatically identifying and addressing missing values marked by special encodings such as -1, -3, and -7, and detecting outliers based on medical expertise to flag physiologically unreasonable values. Additionally, it converts UK Biobank's unique coding system into standard classifications familiar to researchers and cross-validates the logical consistency between related variables to ensure the reliability of the analytical foundation. FastUKB also simplifies the often time-consuming task of generating baseline characteristic tables that meet the standards of top-tier medical journals. By allowing users to select variables and grouping methods, the tool automatically chooses appropriate statistical methods based on data type and distribution, performs relevant statistical tests to calculate between-group P-values, and generates the baseline table seamlessly. Furthermore, it offers a wide range of advanced statistical analysis tools, including linear regression, logistic regression, Cox proportional hazards models, subgroup analysis, interaction analysis, polygenic risk scoring, and sensitivity analysis—all accessible through simple parameter settings, eliminating the need for complex coding.​

Another key advantage of FastUKB is its custom variable upload and smart matching system, which significantly enhances the tool’s flexibility and applicability. Researchers can upload custom ID lists in CSV, XLSX, or TXT formats, and the system will intelligently match and extract data from these specific samples, facilitating precise sample selection for various epidemiological study designs such as cohort and case-control studies. For instance, in case-control studies, users can upload matched control group IDs, and the system can even automatically identify the most suitable matched samples within the UK Biobank based on specified variables like age, gender, and socioeconomic status. This system also supports the upload of custom variables for integration with UK Biobank raw data, including external data from other platforms, derived variables such as disease risk scores, and ensures clear data version control to distinguish between original and user-uploaded data.​

FastUKB has already proven its value in practical applications. In a study exploring the relationship between sleep patterns, genetic risk, and incident rheumatoid arthritis, the tool efficiently extracted sleep behavior indicators from 375,133 participants. Similarly, in a study investigating plasma metabolite profiles linked to the EAT-Lancet diet and inflammatory bowel disease, it facilitated the processing of nearly 900 metabolites, allowing researchers to focus on scientific questions rather than technical details. While currently tailored to the UK Biobank’s data structure and variable encoding system, FastUKB’s modular architecture is designed for scalability, with future development potentially extending its framework to accommodate other large-scale biomedical datasets like FinnGen or All of Us. By lowering the barrier to accessing and analyzing large biomedical datasets, FastUKB democratizes research, accelerates the research cycle, improves research quality, and ultimately contributes to advancing medical knowledge and translating findings into clinical practice.

END